Company profile: Bolt Medical
1.1 - Company Overview
Company description
- Provider of investigational medical devices for calcified arterial lesions, including Bolt IVLTM/Bolt IVL intravascular lithotripsy using laser-based acoustic pressure waves for coronary and peripheral arteries; RESTORE ATK/BTK systems for peripheral arterial disease above/below the knee; and the RESTORE FIH Coronary System, all under clinical evaluation.
Products and services
- Bolt IVLTM System: An investigational intravascular lithotripsy system using laser-based technology to treat calcified coronary and peripheral arterial lesions by creating acoustic pressure waves
- RESTORE FIH Coronary System: A coronary device treating severely calcified coronary lesions, evaluated in a feasibility study to assess safety and efficacy within clinical investigation
- RESTORE ATK System: A system designed for treating peripheral arterial disease above the knee with moderate to severe calcified lesions, currently under clinical investigation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Bolt Medical
Aegerion Pharmaceuticals
HQ: United States
Website
- Description: Provider of biopharmaceutical therapeutics to treat cardiovascular and metabolic diseases, focused on the development and commercialization of therapies, including lomitapide (AEGR-733), a microsomal triglyceride transfer protein inhibitor small molecule drug designed to decrease serum lipids.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aegerion Pharmaceuticals company profile →
Vascular Therapies
HQ: United States
Website
- Description: Provider of biopharma solutions to improve vascular surgery outcomes in patients with kidney and vascular diseases, including Sirogen, a proprietary sirolimus formulation for local perivascular drug delivery, and ACCESS 2, a Phase 3 randomized clinical trial evaluating Sirogen’s effectiveness in improving AV fistula outcomes in elderly hemodialysis patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vascular Therapies company profile →
Innovative Cardiovascular Solutions
HQ: United States
Website
- Description: Provider of novel solutions for full capture and protection from embolic material released during left-sided heart procedures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Innovative Cardiovascular Solutions company profile →
Zewa
HQ: United States
Website
- Description: Provider of bluetooth products, pill boxes, scales, activity trackers, thermometers, pulse oximeters, and blood pressure monitors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zewa company profile →
Aptus Endosystems
HQ: United States
Website
- Description: Provider of advanced endovascular technologies for treating aortic aneurysm disease, focused on EVAR for abdominal aortic aneurysms. Offerings include a unique endograft and an endovascular stapling system that provides a durable alternative to open surgical repair.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aptus Endosystems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Bolt Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Bolt Medical
2.2 - Growth funds investing in similar companies to Bolt Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Bolt Medical
4.2 - Public trading comparable groups for Bolt Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →